IHH Healthcare said its subsidiary has appealed a Tokyo court ruling dismissing damages claims against Daiichi Sankyo over the acquisition of a stake in India’s Fortis Healthcare. The court dismissed Northern TK Venture’s claims on September 10 and ordered IHH’s unit to pay litigation costs. NTK had sought in May 2025 to revise the damages claim to as much as 109.3 billion Indian rupees ($1.14 billion). Separately, IHH plans to increase its Fortis holding to 51% over the next three to five years and further integrate Fortis with its Gleneagles platforms. IHH acquired a 31% Fortis interest through NTK but halted an open offer (public bid to shareholders) for another 26% after Daiichi Sankyo filed a contempt plea against Fortis’s founders.